TXMD
NASDAQ · Pharmaceuticals
Therapeuticsmd Inc
$2.34
+0.05 (+2.18%)
Open$2.29
Previous Close$2.29
Day High$2.40
Day Low$2.28
52W High$2.95
52W Low$0.74
Volume—
Avg Volume21.1K
Market Cap25.93M
P/E Ratio85.85
EPS$0.03
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+407.7% upside
Current
$2.34
$2.34
Target
$11.88
$11.88
$7.57
$11.88 avg
$17.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.80M | 2.04M | 4.86M |
| Net Income | -2,228,506 | -2,275,017 | 1.27M |
| Profit Margin | -123.9% | -117.7% | 26.2% |
| EBITDA | -2,012,844 | -2,169,012 | 2.17M |
| Free Cash Flow | — | — | 1.08M |
| Rev Growth | -11.8% | -11.8% | +8.5% |
| Debt/Equity | — | — | 0.57 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |